Acasă › Leucemie limfatică cronică › North Carolina › Durham
Studii clinice pentru Leucemie limfatică cronică în Durham, NC
27 studii pentru Leucemie limfatică cronică caută participanți în și în jurul orașului Durham (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
În curs de recrutareFaza 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · La 10 mi distanță
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Durham VA Medical Center, Durham
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
În curs de recrutareFaza 3
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · La 10 mi distanță
- University of North Carolina-Hillsborough Campus, Hillsborough · La 13 mi distanță
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
În curs de recrutareFaza 3
- Duke University Medical Center, Durham
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
În curs de recrutareFaza 3
- University of North Carolina At Chapel Hill, Chapel Hill · La 10 mi distanță
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
În curs de recrutareFaza 3
- Duke University Medical Center, Durham
- University of North Carolina At Chapel Hill, Chapel Hill · La 10 mi distanță
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
În curs de recrutareFaza 3
- Duke University, Durham
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
În curs de recrutareFaza 2
- Duke University, Durham
Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia
În curs de recrutareFaza 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · La 10 mi distanță
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
În curs de recrutareFaza 1/2
- UNC School of Medicine, Division of Hematology, Chapel Hill · La 10 mi distanță
Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab
În curs de recrutareFaza 2
- Research Site, Durham
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
În curs de recrutareFaza 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · La 10 mi distanță
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
În curs de recrutareFaza 1
- University of North Carolina at Chapel Hill, Chapel Hill · La 10 mi distanță
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
În curs de recrutareFaza 1
- Duke University Medical Center, Durham
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
În curs de recrutare
- North Carolina Basnight Cancer Hospital, Chapel Hill · La 10 mi distanță
Registry of Older Patients With Cancer
În curs de recrutareStudiu observațional
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · La 10 mi distanță
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
În curs de recrutareFaza 1
- University of North Carolina, Chapel Hill · La 10 mi distanță
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
În curs de recrutareFaza 4
- Duke University Medical Center, Durham
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
În curs de recrutareFaza 4
- Duke University Medical Center, Durham
Study of SGR-1505 in Mature B-Cell Neoplasms
În curs de recrutareFaza 1
- Duke University, Durham
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
În curs de recrutareFaza 2
- University of North Carolina /ID# 233313, Chapel Hill · La 10 mi distanță
Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
În curs de recrutareFaza 2
- The University of North Carolina at Chapel Hill, Chapel Hill · La 10 mi distanță
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
În curs de recrutareFaza 1
- Duke University, Durham
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
În curs de recrutareStudiu observațional
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · La 10 mi distanță
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
În curs de recrutareFaza 2
- Durham VA Medical Center, Durham, NC, Durham
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
În curs de recrutareFaza 1
- University of North Carolina, Chapel Hill · La 10 mi distanță
CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia
În curs de recrutareFaza 1
- Duke University, Durham
Studii pentru Leucemie limfatică cronică în alte orașe
- Boston, MA31 studii
- Columbus, OH28 studii
- Washington, DC22 studii
- Seattle, WA20 studii
- Rochester, MN18 studii
- New York City, NY18 studii
- Houston, TX17 studii
- Baldwin Park, CA16 studii
- Milwaukee, WI15 studii
- Chicago, IL14 studii
- Cincinnati, OH14 studii
- Nashville, TN13 studii
Alte studii în Durham
- Cancer de sân64 studii
- Cancer (toate tipurile)58 studii
- Cancer pulmonar cu celule non-pătrate39 studii
- Mielom multiplu37 studii
- Leucemie mieloasă acută33 studii
- Cancer metastatic33 studii
- Cancer de prostată32 studii
- Cancer pulmonar32 studii
- Cancer colorectal28 studii
- Cancer ovarian27 studii
- Insuficiență cardiacă26 studii
- Cancer pancreatic24 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.